OBJECTIVE: To determine the incidence of loss to follow-up in a treatment programme for people living with human immunodeficiency virus (HIV) infection in Kenya and to investigate how loss to follow-up is affected by gender. METHODS: Between November 2001 and November 2007, 50 275 HIV-positive individuals aged ≥ 14 years (69% female; median age: 36.2 years) were enrolled in the study. An individual was lost to follow-up when absent from the HIV treatment clinic for > 3 months if on combination antiretroviral therapy (cART) or for > 6 months if not. The incidence of loss to follow-up was calculated using Kaplan-Meier methods and factors associated with loss to follow-up were identified by logistic and Cox multivariate regression analysis. FINDINGS: Overall, 8% of individuals attended no follow-up visits, and 54% of them were lost to follow-up. The overall incidence of loss to follow-up was 25.1 per 100 person-years. Among the 92% who attended at least one follow-up visit, the incidence of loss to follow-up before and after starting cART was 27.2 and 14.0 per 100 person-years, respectively. Baseline factors associated with loss to follow-up included younger age, a long travel time to the clinic, patient disclosure of positive HIV status, high CD4+ lymphocyte count, advanced-stage HIV disease, and rural clinic location. Men were at an increased risk overall and before and after starting cART. CONCLUSION: The risk of being lost to follow-up was high, particularly before starting cART. Men were more likely to become lost to follow-up, even after adjusting for baseline sociodemographic and clinical characteristics. Interventions designed for men and women separately could improve retention.
OBJECTIVE: To determine the incidence of loss to follow-up in a treatment programme for people living with human immunodeficiency virus (HIV) infection in Kenya and to investigate how loss to follow-up is affected by gender. METHODS: Between November 2001 and November 2007, 50 275 HIV-positive individuals aged ≥ 14 years (69% female; median age: 36.2 years) were enrolled in the study. An individual was lost to follow-up when absent from the HIV treatment clinic for > 3 months if on combination antiretroviral therapy (cART) or for > 6 months if not. The incidence of loss to follow-up was calculated using Kaplan-Meier methods and factors associated with loss to follow-up were identified by logistic and Cox multivariate regression analysis. FINDINGS: Overall, 8% of individuals attended no follow-up visits, and 54% of them were lost to follow-up. The overall incidence of loss to follow-up was 25.1 per 100 person-years. Among the 92% who attended at least one follow-up visit, the incidence of loss to follow-up before and after starting cART was 27.2 and 14.0 per 100 person-years, respectively. Baseline factors associated with loss to follow-up included younger age, a long travel time to the clinic, patient disclosure of positive HIV status, high CD4+ lymphocyte count, advanced-stage HIV disease, and rural clinic location. Men were at an increased risk overall and before and after starting cART. CONCLUSION: The risk of being lost to follow-up was high, particularly before starting cART. Men were more likely to become lost to follow-up, even after adjusting for baseline sociodemographic and clinical characteristics. Interventions designed for men and women separately could improve retention.
Authors: Kara Wools-Kaloustian; Silvester Kimaiyo; Lameck Diero; Abraham Siika; John Sidle; Constantin T Yiannoutsos; Beverly Musick; Robert Einterz; Kenneth H Fife; William M Tierney Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: Joseph Mamlin; Sylvester Kimaiyo; Stephen Lewis; Hannah Tadayo; Fanice Komen Jerop; Catherine Gichunge; Tomeka Petersen; Yuehwern Yih; Paula Braitstein; Robert Einterz Journal: Am J Public Health Date: 2008-12-04 Impact factor: 9.308
Authors: Jeffrey S A Stringer; Isaac Zulu; Jens Levy; Elizabeth M Stringer; Albert Mwango; Benjamin H Chi; Vilepe Mtonga; Stewart Reid; Ronald A Cantrell; Marc Bulterys; Michael S Saag; Richard G Marlink; Alwyn Mwinga; Tedd V Ellerbrock; Moses Sinkala Journal: JAMA Date: 2006-08-16 Impact factor: 56.272
Authors: Abraham M Siika; Joseph K Rotich; Chrispinus J Simiyu; Erica M Kigotho; Faye E Smith; John E Sidle; Kara Wools-Kaloustian; Sylvester N Kimaiyo; Winston M Nyandiko; Terry J Hannan; William M Tierney Journal: Int J Med Inform Date: 2005-06 Impact factor: 4.046
Authors: Robert M Einterz; Sylvester Kimaiyo; Haroun N K Mengech; Barasa O Khwa-Otsyula; Fabian Esamai; Fran Quigley; Joseph J Mamlin Journal: Acad Med Date: 2007-08 Impact factor: 6.893
Authors: Margaret May; Jonathan A C Sterne; Caroline Sabin; Dominique Costagliola; Amy C Justice; Rodolphe Thiébaut; John Gill; Andrew Phillips; Peter Reiss; Robert Hogg; Bruno Ledergerber; Antonella D'Arminio Monforte; Norbert Schmeisser; Shlomo Staszewski; Matthias Egger Journal: AIDS Date: 2007-05-31 Impact factor: 4.177
Authors: Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger Journal: Lancet Date: 2006-03-11 Impact factor: 79.321
Authors: Mark J Siedner; Alexander Lankowski; Alexander C Tsai; Conrad Muzoora; Jeffrey N Martin; Peter W Hunt; Jessica E Haberer; David R Bangsberg Journal: AIDS Date: 2013-06-01 Impact factor: 4.177
Authors: Cynthia Firnhaber; Laura M Smeaton; Beatriz Grinsztejn; Umesh Lalloo; Sharla Faesen; Wadzanai Samaneka; Rosa Infante; Aadia Rana; Nagalingeswaran Kumarasamy; James Hakim; Thomas B Campbell Journal: HIV Clin Trials Date: 2015-05-15
Authors: Lara Coelho; Peter F Rebeiro; Jessica L Castilho; Yanink Caro-Vega; Fernando A Mejia; Carina Cesar; Claudia P Cortes; Denis Padgett; Catherine C McGowan; Valdiléa G Veloso; Timothy R Sterling; Beatriz Grinsztejn; Bryan E Shepherd; Paula M Luz Journal: AIDS Patient Care STDS Date: 2018-08 Impact factor: 5.078
Authors: Veena G Billioux; Mary K Grabowski; Joseph Ssekasanvu; Steven J Reynolds; Amanda Berman; Jeremiah Bazaale; Eshan U Patel; Eva Bugos; Anthony Ndyanabo; Alice Kisakye; Joseph Kagaayi; Ronald H Gray; Gertrude Nakigozi; Robert Ssekubugu; Fred Nalugoda; David Serwadda; Maria J Wawer; Larry W Chang Journal: AIDS Date: 2018-03-27 Impact factor: 4.177
Authors: S Nimkar; C Valvi; D Kadam; B B Rewari; A Kinikar; N Gupte; N Suryavanshi; A Deluca; A Shankar; J Golub; R Bollinger; A Gupta; I Marbaniang; V Mave Journal: HIV Med Date: 2018-03-24 Impact factor: 3.180